---
title: "GRTX.US (GRTX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GRTX.US/news.md"
symbol: "GRTX.US"
name: "GRTX.US"
parent: "https://longbridge.com/en/quote/GRTX.US.md"
datetime: "2026-05-20T20:18:44.907Z"
locales:
  - [en](https://longbridge.com/en/quote/GRTX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GRTX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GRTX.US/news.md)
---

# GRTX.US (GRTX.US) — Related News

### [Galera Therapeutics Expands Share Authorization, Enhances Stockholder Rights](https://longbridge.com/en/news/286553446.md)
*2026-05-15T11:02:34.000Z*
> Galera Therapeutics has expanded its authorized common stock from 200 million to 400 million shares, approved by stockho

### [Galera Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286406532.md)
*2026-05-14T11:17:32.000Z*
### [](https://longbridge.com/en/news/285095767.md)
*2026-05-04T15:28:40.000Z*
> Assertio Holdings shares are trading higher after the company announced it entered into an Amended and Restated Agreemen

### [13:27 ET$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--LEG, AVNS, GRTX, and GSAT](https://longbridge.com/en/news/283705432.md)
*2026-04-22T17:28:59.000Z*
> Class Action Attorney Juan Monteverde is investigating mergers involving Leggett & Platt (LEG), Avanos Medical (AVNS), G

### [Weight-loss drugs developer Kailera surges 62.5% in Nasdaq debut](https://longbridge.com/en/news/283179748.md)
*2026-04-17T17:27:00.000Z*
> April 17 (Reuters) - Kailera Therapeutics' shares rose 62.5% in their Nasdaq debut on Friday after the weight-loss drug 

### [Kailera Therapeutics Announces Pricing of Initial Public Offering | KLRA Stock News](https://longbridge.com/en/news/283064201.md)
*2026-04-16T15:30:50.000Z*
> Kailera Therapeutics Announces Pricing of Initial Public Offering | KLRA Stock News

### [Obsidian Therapeutics To Merge With Galera In Reverse Merger](https://longbridge.com/en/news/282795257.md)
*2026-04-15T06:40:54.000Z*
> RTW Biotech Opportunities Ltd announced that Galera Therapeutics will merge with Obsidian Therapeutics in a reverse merg